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Abstract
The present study was conducted to synthesize nitrogen containing derivatives of salicyl alcohol 
and to investigate in vivo their ulcerogenic potential in comparison with aspirin in rats. The 
compounds [4-(2-hydroxybenzyl) morpholin-4-iumchloride (I)] and [1,4-bis (2-hydroxybenzyl) 
piperazine-1,4-diium chloride (II)] were synthesized and their chemical structures were 
characterized using spectral data. In our previous study (Ali et al., Afr J Pharm Pharmacol 7, 
585-596, 2013) both compounds showed anti-inflammatory, antinociceptive and antipyretic 
properties in standard animal models and a greater binding affinity for cyclooxygenase-2 vs. 
cyclooxygenase-1 in molecular docking and dynamics analysis.  For in vivo studies, animals 
were randomly divided into four groups. The synthetic compounds (both at 100 or 150 mg/kg), 
aspirin (150 mg/kg) or saline vehicle were administered orally, once daily for six days and then 
tested for ulcerogenic activity. At the end of the procedure, gastric juice and tissues were 
collected and subjected to biochemical and histological analysis. The results of the study 
revealed that in the case of the aspirin treated group, there was a significant increase in gastric 
juice volume, free acidity, total acidity, ulcer score and a decrease in gastric pH. Moreover, 
histological examination of the gastric mucosa of the aspirin treated group indicated 
morphological changes while neither of the synthetic compounds showed any significant 
ulcerogenic or cytotoxic properties. The results of the present study suggest that both compounds 
are free from ulcerogenic side effects and may represent a better alternative to aspirin. 
Keywords  Bioisosteric synthesis. [4-(2-hydroxybenzyl) morpholin-4-ium chloride]. [1,4-bis (2-
hydroxybenzyl) piperazine-1,4-diium chloride]. Acetylsalicylic acid. Ulcerogenicity. Histology 
Introduction
Studies on the pharmacological mechanism(s) underlying nonsteroidal anti-inflammatory drugs 
(NSAIDs) have established an inhibitory link with cycloxygenase (COX) enzyme activity (Amir 
and Shikha, 2004; Smith et al., 1998). There are three isoforms of the COX enzyme (Dannhardt 
and Kiefer, 2001; Marnett and Kalgutkar, 1999) namely COX-1, COX-2 and COX-3; the latter is 
a splice variant of COX-1 not thought to be expressed in humans (Warner and Mitchell, 2004).
Pain, inflammation and pyrexia frequently occur in combination, implicating common mediating 
pathways. So, it is not surprising that inhibitors of COX enzymes are used to treat these clinical 
disorders. COX-1 has a housekeeping or gastroprotective function while COX-2 is inducible and 
is predominantly involved in inflammation, pyrexia and pain (Almansa et al., 2003; Habeeb et 
al., 2001). The majority of the NSAIDs either inhibit all forms of COX enzyme non-selectively 
(Tapiero  et al., 2002) or have greater affinity for COX-1 compared to COX-2 (Jackson and 
Hawkey, 1999). This is thought to be the origin of serious adverse effects such as peptic ulcer, 
perforation and gastrointestinal bleeding (Bulbena et al., 1993; Paulus, 1988; Singh and Rosen, 
1998) associated with the use of NSAIDs and this imposes a major limitation of their therapeutic 
application (Tammara et al., 1994).  
Currently, peptic ulcer is a major global health problem and the search for novel plant-derived or 
synthetic NSAID molecules devoid of ulcerogenic propensity, is an active area of investigation 
for biomedical researchers (Tammara et al., 1994). Certain biochemical actions of drugs are 
clinically advantageous in the diagnosis or treatment of disorders, yet others may be detrimental 
giving rise to adverse effects. Hence, alterations in chemical structure are necessary to enhance 
beneficial properties.  
A range of biochemical activities have been reported for glycosides and it is principally the genin 
(aglycone) moiety which is responsible for these actions (Robyt, 1998; Salga et al., 2011; Yoon 
et al., 2004). Salicin (2-(hydroxymethyl) phenyl-β-D-glucopyranoside) is a glycoside chemically 
related to aspirin which may be hydrolyzed to yield salicyl alcohol (2-hydroxy methyl phenol or 
saligenin) (Table 1). Salicin has been reported to be an anti-rheumatic, anti-inflammatory and 
antipyretic pro-drug with no propensity to induce gastric damage (Akao et al., 2002; Yoon et al., 
2004). These properties of salicin which is devoid of a –COOH group prompted the bioisosteric 
synthesis of new compounds lacking this group with a targeted pharmacological profile. 
Evidence regarding anesthetic as well as antipyretic activities of salicin have been reported 
(Charles and Tony, 1956; Machagan, 1876). The compounds under current study are bioisosteres 
derived from salicyl alcohol, via incorporation of pharmacologically important morpholine and 
piperazine moieties. Other compounds comprising such moieties inhibit eicosanoid pathways 
and exhibit varied pharmacological properties including antiproliferative activities (Berardi et al., 
2008; Coonrod et al., 2001; Nozawa et al., 2007). In this regard, the piperazine moiety has been 
proposed as a critical core for novel drug design (Bali et al., 2010) and morpholine substitution 
in heterocyclics has yielded both anti-inflammatory and antinociceptive properties 
(Panneerselvam et al., 2009). 
Bearing in mind the concept of salicin as a prodrug and the potential for pharmacological 
properties of compounds with morpholine or piperazine substitution, we performed the 
bioisosteric synthesis of compounds I [4-(2-hydroxybenzyl) morpholin-4-iumchloride] and II 
[1,4-bis(2-hydroxybenzyl)piperazine-1,4-diiumchloride] (Table 1, Fig. 1) and evaluated their
ulcerogenic propensity. 
 In light of this, it is noteworthy that we have recently reported these compounds to possess 
significant anti-nociceptive, anti-inflammatory and anti-pyretic activities comparable to aspirin 
in animal models which were supported by molecular docking and dynamics simulation studies 
(Ali et al., 2013). Consequently, we now wished to establish the gastrointestinal tolerability of 
these compounds in comparison with aspirin. 
Methods and materials 
Chemicals 
Bovine serum albumin and acetylsalicylic acid were obtained from Sigma. The starting materials 
were either purchased from Aldrich and Sigma or prepared by standard procedures available in 
the literature. All other chemicals used were of analytical grade and acquired commercially from 
local sources. 
Chemistry 
General 
Infrared spectra (IR) were determined on a Nicolet 380 thermoscientific FTIR. Mass spectra 
were recorded on a JEOL MSRoute spectrometer and nuclear magnetic resonance (NMR) 
spectra scanned on a BRUKER 300-MHz spectrophotometer using D2O as a solvent. Melting 
points (mp) of compounds were determined using a Gallenkamp Melting Point apparatus. The 
chemical shifts were presented as parts per million (δ ppm) using tetramethylsilane (TMS) as an 
internal standard.
Synthesis 
Compound I [4-(2-hydroxybenzyl)morpholin-4-ium chloride] and compound II [1,4-bis(2-
hydroxybenzyl)piperazine-1,4-diium chloride] were synthesized (Fig. 1) using salicylaldehyde as 
a starting material according to the following synthetic protocol. A mixture of NaBH4 (10 
mmol), salicylaldehyde (10 mmol), and boric acid (10 mmol) were milled with mortar and pestle 
until thin layer chromatography exhibited entire vanishing of the starting material. The reaction 
mixture was quenched with a 10 ml solution of 1N HCl and extracted with ethyl acetate. The 
ethyl acetate layer was separated and dried over sodium sulfate. On evaporation of the solvent, 
pure salicyl alcohol was obtained, which was used in further reactions without purification.
Thionyl chloride (1.19 g, 10mmol) was slowly added to a solution of salicyl alcohol (1.24 g, 10 
mmol) in dichloromethane at room temperature. After the addition of thionyl chloride the 
reaction mixture was refluxed for 2 h. The reaction mixture was cooled to 0 
o
C and amine (10 
mmol) was slowly added to it. The product was precipitated as a white powder. The product was 
filtered, washed with dichloromethane and kept under vacuum for 24 hr. Their chemical 
structures were confirmed from IR, 
1
H and 
13
C NMR and MS data. 
4-(2-hydroxybenzyl) morpholin-4-ium chloride (Compound I)   
Yield 56.0 %; mp 140 ºC; IR (neat): 3391, 3048, 2944, 1604, 1432, 1130, 793; 
1
H NMR (300 
MHz, D2O):  δ 7.32-6.95 (m, 4H), 4.69 (s, 2H), 3.87 (t, J = 5.1Hz, 4H), 3.22 (t, J = 5.1Hz, 4H); 
13
C NMR (75 MHz, D2O): δ 45.7 (2C), 53.6, 66.2 (2C), 118.4, 123.1, 123.1, 134.7, 135.6, 159.3; 
MS (m/z): M
+
 193, 146, 134, 107, 86, 76. CHN analysis required for C11H16ClNO2: C, 57.52; H, 
7.02; N, 6.10. Found: C, 57.32; H, 6.88; N, 5.84. 
1,4-bis(2-hydroxybenzyl)piperazine-1,4-diium chloride (Compound II) 
Yield 62.3 %; mp 230 ºC (Decomposition); IR (neat): 3479, 3007, 2926, 2783, 1620, 1433, 
1139; 
1
H NMR (300 MHz, D2O): δ 7.29-6.91 (m, 8H), 4.69 (s, 4H), 3.49 (s, 8H); 13C NMR (75 
MHz, D2O): δ 43.0 (4C), 50.8 (2C), 118.4 (2C), 119.2 (2C), 123.2 (2C), 134.2 (2C), 134.9 (2C), 
158.2 (2C); MS (m/z): M
+
 298, 278, 192, 107, 85, 56. CHN analysis required for C18H24Cl2N2O2: 
C, 58.23; H, 6.52; N, 7.54. Found: C, 57.97; H, 6.43; N, 7.39. 
Pharmacology 
Animals and animal husbandry 
Sprague-Dawley rats of either sex (150-200 g) were used in the study. The animals were bred in 
the Animal House and Bioassay Laboratories of the Department of Pharmacy, University of 
Peshawar. Animals were kept in standard cages with free access to standard laboratory food and 
water available ad libitum. Experiments were conducted between 8:00am-4:00pm, on a 12hr-
12hr light dark cycle with temperature maintained at 22±2ºC.  
Ethical approval 
The study was approved under the project entitled “Evaluation of the anti-inflammatory, 
antinociceptive and antipyretic activities of selected synthetic and natural compounds in animal  
models” by the “Ethical Committee of Department of Pharmacy, University of Peshawar, 
Peshawar, Khyber Pakhtunkhwa (KP), Pakistan” in its 3rd meeting held on June 15, 2011 and an 
approval certificate bearing number 15/EC/Pharm was obtained.  
Evaluation of ulcerogenicity of aspirin, compound I (4-(2-hydroxybenzyl) morpholin-4-ium 
chloride), compound II (1, 4-bis (2-hydroxybenzyl) piperazine-1,4-diium chloride )  
Evaluation of the ulcerogenic effects of aspirin, compound I and II was carried out according to a 
method reported previously (Virupaksha and Shivkumar, 2008).  Briefly, the animals were 
randomly divided into four treatment groups (n=6 each). Treatments, doses and the route of 
administration are summarized in Table 2.  
Drug administration and surgical procedure
Test compounds and aspirin in their respective doses, were dissolved in normal saline vehicle 
and administered orally (p.o.) by feeding tube once a day for six days. The final dose for each 
group was administered to 36-hour fasted animals 1 hour prior to a pyloric ligation procedure 
(Mabrouk et al., 2009) under ketamine (i.p.) anesthesia. Keeping in view the relationship 
between an empty stomach, increased acidity and the propensity for ulcerogenicity, we opted for 
a 36-hour fasting period (extended duration).The majority of NSAIDs are readily absorbed from 
the gastrointestinal tract (GIT) within 60 minutes of administration to produce systemic effects. 
However, there is a relatively prolonged gut transit time after oral administration increasing the 
possibility of localized effects on the gastric mucosa after 60 min. Consequently, we have 
selected a one-hour pretreatment period for the test compounds prior to the ligation procedure.  
During the surgical procedure, the stomach was carefully exposed and the pyloric sphincter was 
immediately ligated with surgical silk avoiding any injury to blood vessels and the abdominal 
wall was subsequently reclosed with sutures prior to recovery. Food and water were withheld for 
4 hours to permit gastric juice to accumulate and after killing, the stomachs were re-exposed. A 
knot was applied at the esophageal end to avoid drainage of gastric juice and samples of the 
stomach tissue were dissected for histological studies. 
Macroscopic assessment of stomach mucosa 
After ligation for 4 hrs, each stomach was removed and opened along the greater curvature to 
assess the degree of ulceration in terms of ulcer score under a magnifying glass (10X). Ulcer 
scoring was performed according to a previously reported method (Patidar, 2011) as depicted in 
Table 3. 
Biochemical gastric juice analysis 
The volume of collected gastric juice was measured then; it was centrifuged at 1000 rpm for 10 
minutes at room temperature and the supernatant separated for pH, free acidity, total acidity and 
pepsin determination. Gastric parietal cells produce hydrochloric acid (HCl), which can exist in 
the gastric juice either as free HCl representing free acidity and HCl bound to other acidic 
compounds including acidic proteins in the gastric juice (bound acidity). The term total acidity is 
used to designate the sum of the free acidity, bound acidity and acidity due to other weak acids 
(organic acids and proteins).  
Two to three drops of Topfer’s reagent (dimethylamino-azobenzene) were added to 1mL of 
supernatant and titrated against 0.01N NaOH the end point being a color change from light red to 
yellowish orange. The volume (ml) of alkali required represents free acidity and was determined 
by the following formula  (Patidar, 2011; Reddy et al., 2012). 
Acidity = Volume of NaOH × N × 100 mEq/L/0.1 
where N= normality of NaOH 
Total acidity was determined by adding phenolphthalein indicator and titration with 0.01N 
NaOH continued until a red color reappeared. The volume of alkali consumed was substituted in 
the acidity equation above (Anoop and Jegadeesan, 2003; Kore Kakasaheb et al., 2011; 
Muniappan and Sundararaj, 2003).  
To determine pepsin activity, gastric juice (0.1 ml) was mixed with 1 ml of 0.5% of bovine 
serum albumin (BSA) in 0.01N HCl. The mixture was then incubated at 37
 O
C for 20 minutes. A 
gastric juice blank containing no albumin was prepared by adding 1ml of 0.01N HCl. After 
incubation, the hydrolysis reaction was halted using 2 mL of 10 % TCA (trichloroacetic acid). 
All tubes were heated in a boiling water bath for 5 minutes which caused protein denaturation, it 
was then cooled and the precipitate was removed by centrifugation (9000 xg, 10 minutes). To 1 
ml of supernatant sample of each tube 0.4 ml NaOH (2.5N) plus 0.1ml Folin-Ciocalteau phenol 
reagent was added. Lastly, volume was adjusted with distilled water up to 10 mL and protein 
absorbency was measured with ultraviolet visible (UV/VIS) spectrophotometer at 700 nm 
wavelength. Activity was expressed in terms of micro moles of tyrosine/ml or mg/dl bovine 
serum albumin (Kalra et al., 2011). 
Histological determination of ulcerogeneic effect of compound I [4-(2-hydroxybenzyl) 
morpholin-4-ium chloride], compound II [1,4-bis(2-hydroxybenzyl) piperazine-1,4-diium 
chloride] and aspirin. 
Gastric tissues were collected at the end of the experimental procedure and subjected to 
histological examination using a rotary microtome (SLEE Mainz CUT 5062, Germany) to 
produce 3 µm tissue sections and a light microscope (Labomed Lx 400 USA with digital camera 
Labomed iVu 3100). Practice procedures were employed for tissue processing and hematoxylin 
and eosin (H & E) staining with slight modifications (Falkeholm et al., 2001). 
Results 
Effects of compound I, compound II and aspirin on biochemical parameters 
One way ANOVA followed by Dunnett’s post hoc analysis revealed significant biochemical 
changes in gastric juice volume, pH, free acidity and total acidity but not pepsin concentration in 
the aspirin treated group. No biochemical changes were observed for the compound I and 
compound II treated groups (Figures 2a, 2b, 2c, 2d and 2e).  
Effects of compound I, compound II and aspirin on the gross photomicrographic 
appearance of stomach mucosae 
Examination of photomicrographs, revealed no gross morphological changes such as spot ulcers 
or, hemorrhagic streaks in the stomach mucosae of animal groups treated with compounds I and 
II and saline. However, visually detectable changes were observed in the mucosae of the aspirin 
treated group (Figures 3a, 3b, 3c, 3d, 3e and 3f).  
Effects of compound I, compound II and aspirin on ulcer score and body weight
One way ANOVA followed by Dunnett’s post hoc analysis revealed a significant increase in 
ulcer score (P<0.001) in the aspirin but not in the compound I and II treated groups (Figure 4a). 
No significant change in body weight was observed in all treated groups (Figure 4b). 
Effects of compound I, compound II and aspirin on gastric histology 
Results of histological examination of control, aspirin, compound I and compound II are 
depicted in Fig. 5a, 5b, 5c, 5d, 5e and 5f [H & E stain; 10X]. Histological examination of gastric 
mucosae showed that oral administration of compound I and compound II resulted in no 
significant morphological changes. On the other hand, changes like disruption of epithelial lining 
and edema were clearly observed in the case of the aspirin treated group (Fig. 5b). 
Discussion
The synthesized salicyl alcohol nitrogen containing derivatives i.e. compound I and compound II 
were evaluated for ulcerogenic properties in comparison with aspirin. The finding of this study 
indicated that these compounds were devoid of  ulcerogenic properties as there was no change in 
both biochemical and histological parameters at doses that have shown significant anti-
nociceptive, anti-inflammatory and antipyretic activities (Ali et al., 2013). 
There is an explicit need for a substitute to classical nonsteroidal anti-inflammatory drugs such 
as aspirin possessing effective anti-inflammatory, anti-nociceptive and antipyretic activities yet 
but devoid of serious adverse effects like GIT ulceration, hemorrhage and perforation (Singh and 
Rosen, 1998).   
Utilizing FRED 2.1 and MOE software, molecular docking  and dynamics analyses have shown 
better binding energy of these compounds with cycloxygenase-2 (COX-2) enzyme,  predicting 
these compounds as potential COX-2 inhibitors (Ali et al., 2013). Based on computational 
studies, the compounds have exhibited dose dependent antinociceptive, anti-inflammatory and 
antipyretic activities in animal models. Nonetheless, these compounds did not show 
antinociceptive properties in the hot plate test when compared with centrally acting standard 
analgesic (morphine), thus suggesting a peripheral mechanism of action in the mediation of anti-
nociception (Ali et al., 2013). 
Bioisosterism has unique relevance in the field of pharmaceutical sciences and is performed to 
curtail side effects or to alter the activity of a target molecule (Wanget al., 2003). In the 
biomedical field, the aim of exchanging one bioisostere for another is to boost the preferred 
pharmacological, biological or physical qualities of a substance without making substantial 
changes in the chemical skeleton (Lima and Barreiro, 2005; Patani et al., 1996).  
In this study, salicyl alcohol with its nitrogen containing derivatives, that is compounds I and II, 
were investigated for ulcerogenic potential in comparison to aspirin. The doses of the compounds 
selected for this study (100 and 150 mg/kg) were based on our previous observations that these 
doses possessed significant antinociceptive, anti-inflammatory and antipyretic activities (Ali et 
al., 2013). 
 Results of the current study clearly demonstrated that treatment with I and II, compared to 
aspirin, lacked ulcerogenic potential as there was no significant change in gastric juice volume, 
pH, free or total acidity, pepsin concentration or ulcer score. Since these compounds possess 
neutral characteristics, it may be concluded that their presence in the stomach may not have 
influenced either the acidity or other biochemical parameters of gastric juice to any significant 
extent.  
The gross appearance of gastric mucosa revealed an absence of morphological changes like ulcer 
spot or hemorrhagic streaks in the saline vehicle control treated as well as compound I and 
compound II treated groups in contrast to the aspirin group where such changes were clearly 
evident. Moreover, histological examination of the stomach tissues revealed no surface epithelial 
disruption, deep mucosal damage, edema, necrotic lesion or leucocytes infiltration following 
treatment with saline, compound I or compound II while changes like mucosal disruption and 
edema were visible in the group treated with aspirin. Furthermore, during the entire period of the 
study, no significant changes in body weight or any other sign of toxicity were observed in the 
compound I and compound II treated animals.  
The lack of ulcerogenic properties of compound I and II may be attributed to the absence of a 
free carboxylic acid group (-COOH) which is generally considered an important contributor 
towards the ulcerative properties of the majority of NSAIDs including aspirin (Shanbhag et al., 
1992). Additionally, as evidenced by our previous evaluation studies on molecular docking and 
dynamics simulation, these compounds interact with COX II thus favoring non-ulcerogenic 
properties (Ali et al., 2013).  
Conclusions 
In summary, the current study presents the bioisosteric synthesis and evaluates the ulcerogenic 
potential of the synthetic compounds (I and II) versus aspirin. Our findings clearly indicate that 
unlike aspirin, these compounds lack significant ulcerogenic properties that might be ascribed to 
selective inhibition of COX-II enzyme, the absence of a free carboxylic acid moiety and 
consequently, the neutral characteristics of these compounds.  
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Table 1. Chemical structures of salicin, salicyl alcohol, compound I, II and acetyl salicylic acid. 
Chemical structures
Salicin
Salicyl alcohol
Compound (I)
[4-(2-hydroxybenzyl) morpholin-4-ium chloride]
Compound (II)
[1,4-bis(2-hydroxybenzyl)piperazine-1,4-diium chloride]
Acetyl salicylic acid
        Table 2.      Distribution of animals in treatment groups. 
Group 
No.
Treatment group Dose
( mg/kg)
Route
(per os)
I Saline control  (untreated) - p.o
II Standard treatment group (Aspirin) 150 p.o
III Test treatment group (compound I) 100 p.o
150
IV Test treatment group (compound II) 100 p.o
150
         Table 3.         Determination of ulcer score. 
Mean ulcer score for each animal group was calculated. 
Score Observation
0 Normal stomach
0.5 Red coloration
1.0 Spot ulcers
1.5 Hemorrhagic streaks
2.0 Ulcer number ≥ 3 but ≤5
3.0 Ulcer number > 5
Figure 1. Synthesis of compound I [4-(2-hydroxybenzyl)morpholin-4-ium chloride] and 
compound II [1,4-bis(2-hydroxybenzyl)piperazine-1,4-diium chloride]. 

Figure 2.  Effect of aspirin, compound I, II on gastric juice volume, pH, free acidity, total acidity 
and pepsin concentration. Saline (control), aspirin (150 mg/kg), compounds I and II (100 and150 
mg/kg) were administered once a day orally for six days. The final dose was administered to 36-
hour fasted rats in each experimental group 1 hr before pyloric ligation. Four hrs after surgery, 
gastric juice was collected and analyzed for volume (Figure 2a), pH (Figure 2b), free acidity 
(Figure 2c), total acidity (Figure 2d) and pepsin concentration (Figure 2e). Data presented as 
mean ± S.E.M. (n=6) compared to the saline vehicle treated group **P<0.01, ***P<0.001 (One 
way ANOVA followed by Dunnett’s post-hoc analysis). 
Figure 3. Gross photomicrographic appearance of the gastric mucosae of saline (control) (Figure 
3a), compound I (100mg/kg, Figure 3b; 150 mg/kg, Figure 3d), compound II (100 mg/kg, Figure 
3c; 150 mg/kg; Figure 3e) and aspirin (150 mg/kg; Figure 3f) treated groups. For each condition 
(repeated 6 times) a representative photomicrograph is shown (n=6).  
Figure 4. Effect of aspirin, compound I, II on ulcer score and body weight. A significant 
increase in ulcer score was observed for the aspirin but not for the compound I and II treated 
groups (Figure 4a). There was no significant change in body weight of any treated group (Figure 
4b) (n=6 each). ***P<0.001 (One way ANOVA followed by Dunnett’s post-hoc analysis). 
Figure 5.  Histological ulcerogenic effects of control, aspirin, compound I or 
compound II (H & E staining; 10x original magnification) (n=6 each). 
Representative photomicrographs of the glandular portion of the stomach: (a) the 
saline (control group) showing normal appearance of mucosa (bar) and submucosa 
(asterisk), (b) aspirin treated group (150 mg/kg) showing erosion with disruption of 
mucosa (large arrow) and inflammatory exudates (small arrow). Normal histological 
appearance of mucosa (bar) and sub mucosa (asterisk) were found in groups of 
animals treated with: (c) compound I (100 mg/kg), (d) compound I (150 mg/kg), (e)
compound II (100 mg/kg) and (f) compound II (150 mg/kg). 
